DETERMINATION OF NAPROXEN BY SPECTROFLUOROMETRY AND ITS BINDING TO SERUM-PROTEINS

被引:0
作者
MORTENSEN, A
JENSEN, EB
PETERSEN, PB
HUSTED, S
ANDREASEN, F
机构
[1] AARHUS UNIV, INST PHARMACOL, DIV CLIN PHARMACOL, DK-8000 AARHUS, DENMARK
[2] AARHUS UNIV, INST MATH, DEPT THEORET STAT, DK-8000 AARHUS, DENMARK
[3] AARHUS AMTSSYGEHUS, DEPT MED 1, DK-8000 AARHUS, DENMARK
来源
ACTA PHARMACOLOGICA ET TOXICOLOGICA | 1979年 / 44卷 / 04期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A fluorometric method for the determination of naproxen in serum, albumin solutions and protein free buffer solutions is described. The detection limit is about 10 ng/ml. Furosemide, thiopental and salicyclic acid did not show any disturburing fluorescence while phenprocoumon did. The in vitro binding of naproxen in albumin solutions and serum was studied by equilibrium dialysis. A small but significant increase was found in the percentual binding in albumin solutions as compared to serum. The percentual binding was not affected by changes in the pH from 5-8. By fitting the binding data to a model assuming 2 classes of binding sites, association constants and binding capacities were determined. A very high affinity and a high capacity were found. The association constant for the first class of binding sites was higher for human serum albumin than for serum (8.5 vs. 5.3 .cntdot. 106 M-1). The difference in the protein binding to the first class of binding sites in human serum albumin and serum can be explained by the existence of a competitive inhibitor in serum.
引用
收藏
页码:277 / 283
页数:7
相关论文
共 17 条
[1]   FLUOROMETRIC-DETERMINATION OF NAPROXEN IN SERUM [J].
ANTTILA, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) :433-434
[2]   MECHANISMS OF ACTION OF ANTI-INFLAMMATORY DRUGS [J].
BRUNE, K ;
GLATT, M ;
GRAF, P .
GENERAL PHARMACOLOGY, 1976, 7 (01) :27-&
[3]   PROTEIN-BINDING OF ANTIMICROBIALS - CLINICAL PHARMACOKINETIC AND THERAPEUTIC IMPLICATIONS [J].
CRAIG, WA ;
WELLING, PG .
CLINICAL PHARMACOKINETICS, 1977, 2 (04) :252-268
[4]  
Ellis DJ, 1971, FED PROC, V30, P864
[6]  
FORREY AW, 1974, CLIN CHEM, V20, P152
[7]   OVERVIEW OF DRUG-PROTEIN BINDING [J].
GILLETTE, JR .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1973, 226 (NOV26) :6-17
[8]  
JANSEN JA, 1977, ACTA PHARMACOL TOX, V41, P401
[9]  
KENDALL MG, 1968, ADV THEORY STAT, V2, P55
[10]   POTENTIAL EFFECT OF PLASMA PROTEINS ON DRUG DISTRIBUTION [J].
MARTIN, BK .
NATURE, 1965, 207 (4994) :274-&